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Tbjective: The purpose of this study was to investigate the effects of cardiopulmo-
ary bypass and ultrafiltration on graft function in a canine single-lung transplan-
ation model.
ethods: Fifteen left single-lung transplantations were done in weight-mismatched
anine pairs. The animals were divided into 3 groups: group 1, in which transplan-
ation was done without cardiopulmonary bypass; group 2, in which transplantation
as done with cardiopulmonary bypass and in which the cardiopulmonary bypass
ow was decreased slowly with controlled pulmonary artery pressure; and group 3,
n which transplantation was done with cardiopulmonary bypass and ultrafiltration.
emodynamic parameters and lung function were monitored for 6 hours after
eperfusion. The grafts were harvested for histologic studies, myeloperoxidase
ssay, and real-time quantitive reverse transcription–polymerase chain reaction of
RNA encoding interleukin 6.
esults: The hemodynamic parameters were similar among the 3 groups. In group
PaO2 and alveolar to arterial gradient for O2 levels were excellent throughout the
-hour observation period, but in group 2 they progressively deteriorated. However,
ltrafiltration significantly (P  .02) improved the PaO2 level in group 3. On
istology, interstitial edema and polynuclear cell infiltration were most marked in
roup 2 and significantly worse than in groups 1 and 3. Myeloperoxidase assay and
eal-time quantitative reverse transcription–polymerase chain reaction showed in-
reased myeloperoxidase activity and interleukin 6 gene expression in group 2 grafts
ompared with group 1 grafts. Myeloperoxidase activity and interleukin 6 gene
xpression were suppressed with ultrafiltration.
onclusions: Cardiopulmonary bypass had negative effects on the graft, but ultra-
ltration attenuated acute lung dysfunction by reducing the inflammatory response.
he use of cardiopulmonary bypass (CPB) is limited to a minority of lung
transplant recipients because CPB has been associated with inferior early
graft function and clinical outcome. Several reports have found that the
ortality and morbidity of recipients requiring CPB is higher than that of recipients
ot requiring CPB.1-3 One of the reasons for these findings could be that 
vokes an inflammatory response that leads to organ failure, including respiratory
istress syndrome.4-6 In cardiac surgery CPB is well recognized to cause a sys
nflammatory response syndrome that can progress to acute lung inflammation
nown as postperfusion syndrome.
On the other hand, Triantafillou and colleagues7 reported that CPB has n
eleterious effect on early graft function. In pediatric transplantation most opera-
ions are performed with CPB, and good results have been reported. In fact, the
arefield group recommends the routine use of CPB in lung transplantation.8
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 6 1447
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1
TXurthermore, Szeto and associates9 have found that CP
ad minimal deleterious effects on graft function in a ho-
ogeneous population of patients with chronic obstructive
ulmonary disease. Thus the use of CPB in lung transplan-
ation is controversial. The reason for a lack of consensus is
artially due to the fact that clinical studies can be biased
ecause patients who require CPB have more severe dis-
ase. In particular, CPB is mostly needed in patients with
ulmonary hypertension, and this group of patients has the
ighest risk of all patients undergoing transplantation. There
ave been no randomized controlled studies to address the
ffects of CPB on the outcomes of lung transplantation, and
ew experimental studies have specifically examined the
ffects of CPB on graft function.
Theoretically, CPB has potential benefits, such as pro-
iding hemodynamic stability during surgical intervention
nd preventing the sudden increase of pulmonary flow dur-
ng the reperfusion period. Thus controlling graft flow with
PB might protect the graft from high-pressure reperfusion
njury. Halldorsson and coworkers10,11 reported that de-
reasing the reperfusion pressure prevents pulmonary injury
n a piglet model. On the other hand, the Pittsburgh group
eported that the use of CPB is associated with early graft
ysfunction in a canine experiment.12 Fullerton and col-
eagues13 reported that lung transplantation with CPB -
ggerates pulmonary vasomotor dysfunction. However, in
heir experiment the animals were quickly weaned off CPB,
nd the potential benefit of CPB was not examined. We
ypothesized that the effect of CPB on lung function de-
ends on the balance between its deleterious effects caused
y an inflammatory response and its beneficial effects
aused by decreasing pulmonary flow. To examine the
eneficial effects of CPB on graft function, we performed
anine single-lung transplantations with CPB, and graft
ow was controlled during the early reperfusion period. In
ddition, we examined whether conventional ultrafiltration
CUF) during CPB attenuates graft dysfunction because it
Abbreviations and Acronyms
ANOVA analysis of variance
BAL  bronchoalveolar lavage
CO  cardiac output
CPB  cardiopulmonary bypass
CUF  conventional ultrafiltration
CVP  central venous pressure
IL-6  interleukin 6
LAP  left atrial pressure
MPO myeloperoxidase
MUF modified ultrafiltration
PMN  polymorphonuclear neutrophil
W/D  wet/dry weightas recently been suggested that ultrafiltration is effective in S
448 The Journal of Thoracic and Cardiovascular Surgery ● Decliminating the inflammatory mediators responsible for the
ytokine syndrome.14
aterials and Methods
ifteen left single-lung transplantations were done in weight-
ismatched pairs of adult mongrel dogs. Dogs weighing from 20
o 21 kg were used as donors, and smaller dogs weighing from 15
o 17.5 kg were used as recipients. The donor/recipient body
eight ratio ranged from 1.2 to 1.25. Weight-mismatched pairs of
ogs were used because Fujita and associates15 found that th
onor/recipient body ratio had an important effect on early graft
unction; a donor/recipient body weight ratio of 1.2 or greater was
ssociated with stable graft function.
The animals were divided into 3 groups: group 1, in which
ransplantation was done without CPB; group 2, in which trans-
lantation was done with CPB and CPB flow was decreased slowly
ith controlled pulmonary artery pressure; and group 3, in which
ransplantation was done with CPB and ultrafiltration was used
ntil the termination of CPB.
onor Procedure
nesthesia was induced with intramuscular ketamine hydrochlo-
ide (10 mg/kg) and atropine (0.01 mg/kg). Intravenous thiopental
odium (2.5 mg/kg) and pancuronium bromide (0.1 mg/kg) were
sed to facilitate endotracheal intubation. The animals were ven-
ilated at a tidal volume of 15 mL/kg at a rate of 15 breaths/min by
sing a volume-limited ventilator (Servo 900B, Siemens-Elmer).
ositive end-expiratory pressure was controlled at 5 cm H2O; the
nspired oxygen fraction was 1.0. Anesthesia was maintained with
nhalation of 1% to 2% halothane, and muscular relaxation was
btained with additional pancuronium bromide at a dose of 0.5
g/kg. An arterial line was inserted into the right femoral artery to
onitor blood pressure and arterial blood gases. A venous line was
nserted into the right femoral vein to allow infusion of solutions.
left thoracotomy was performed at the fifth intercostal space.
he left and right pulmonary arteries, pulmonary vein, and left
ain bronchus were isolated. Sodium heparin (300 U/kg) was
dministered through the venous line. A purse-string suture with
-0 Prolene was placed on the proximal site of the left pulmonary
rtery, and a catheter was inserted. A vascular clamp was placed
n the left atrium, and an incision was made for decompression.
fter left pulmonary artery clamping, the left lung was selectively
ushed with cold modified Euro-Collins solution (50 mL/kg).
uring this period, the lung was ventilated with 100% oxygen.
fter flushing was completed, the left main bronchus was stapled,
eaving the lung well inflated with 100% oxygen. The left lung was
hen excised and stored in 4°C Euro-Collins solution until trans-
lantation. During pulmonary artery flushing, donor blood for the
ecipients’ transfusion was collected into packs containing citrate-
hosphate-dextrose solution from the venous line. After harvesting
he left lung, the animals were killed by means of an intravenous
njection with an overdose of potassium chloride and thiopental
odium.
ecipient Procedure
ecipient dogs were anesthetized and ventilated, and catheters
ere inserted as in the donors. A pulmonary artery catheter (5F
wan-Ganz catheter) was placed in the main pulmonary artery
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TXrom the left internal jugular vein to monitor pulmonary artery
ressure, central venous pressure (CVP), and cardiac output (CO).
ith the animals in the right decubitus position, a left thoracotomy
as done through the fifth intercostal space. The right pulmonary
rtery and the right main bronchus were encircled by 1-0 silk
trings. Sodium heparin (300 U/kg) was administered systemi-
ally, and the activated clotting time was confirmed to be longer
han 400 seconds. A catheter was placed into the left atrium
hrough the right accessory pulmonary vein to monitor left atrial
ressure (LAP). In group 1 a left pneumonectomy was performed,
nd then the donor left lung was orthotopically transplanted. In
roups 2 and 3 a pediatric arterial cannula was inserted in the distal
art of the ascending aorta, and a 2-stage wire-reinforced venous
annula (28F, 38F) was placed in the right atrium by opening the
ericardium through a left thoracotomy. The arterial and venous
annulas were connected to the bypass circuits, which consisted of
roller pump, a 2000-mL venous reservoir, 3⁄8-inch tubing, a 40-m
rterial filter, a polystan oxygenator (SAFE MINI, Polycare Ltd), and
heat exchanger. The bypass circuit was primed with 500 mL of
actate Ringer’s solution, 20% mannitol, and sodium bicarbonate.
PB was initiated and maintained at a flow rate of 80 to 100
L/kg for 2 hours, and rectal temperature was maintained at 36°C.
uring CPB, the respiration rate was decreased to 6 breaths/min.
he left pneumonectomy and lung transplantation were done in
he same manner as in group 1. When the animals were weaned
ff CPB, the CPB flow was decreased slowly so that the newly
ransplanted lungs were reperfused with a controlled pulmonary
rtery pressure over a 10-minute period. In all groups trans-
lantation involved about 20 hours of ischemic time. All ani-
als were transfused with donor blood if the hematocrit level
ecreased to less than 20%. The donor blood was endotoxin free
nd a negative cross-match. In all groups protamine was ad-
inistered to neutralize heparin, and the activated clotting time
as normalized. After 30 minutes of reperfusion, the native right
ulmonary artery and right main bronchus were ligated to ensure
ependence on the transplanted lung. The lungs were ventilated
ith a tidal volume of 15 mL/kg, a positive end-expiratory pres-
ure of 5 cm H2O, and an inspired oxygen fraction of 1.0 at a rate
f 20 breaths/min. The skin was closed, and the recipient dogs
ere observed for 6 hours, during which time aortic pressure,
ulmonary artery pressure, CVP, and LAP values were continu-
usly monitored. Measurement of CO, arterial blood gas analysis,
nd blood sampling was done at 60, 120, 180, 240, 300, and 360
inutes after ligation of the right pulmonary artery and the right
ronchus. CO was measured by means of the thermodilution
echnique with a 5-mL bolus injection of 5% glucose at 4°C.
rterial gas was analyzed with the i-STAT portable clinical ana-
yzer (Heska Corp). Bronchoalveolar lavage (BAL) was done
wice by means of flexible bronchoscopy, once before transplan-
ation and again 360 minutes after ligation of the right pulmonary
rtery and the right bronchus. The bronchoscope was wedged in
he lingular segment of the left upper lobe. The BAL fluid was
ollected by flushing the distal airways with 2  10 mL of
ormal saline and consequent intermittent suctioning. After 6
ours of observation, the animals were killed with an intrave-
ous injection of an overdose of potassium chloride and thio-
ental sodium. (
The Journal of Thoracicltrafiltration
n group 3 the ultrafiltration circuit was arranged as follows. One
f the outlet ports of the arterial line was connected to a hemocon-
entrator (Capiox CX-HC05S, Terumo Corp) through a small
oller pump. A polysulfon fiber with a surface of 0.5 m2, a priming
olume of 34 mL, and a maximal transmembranous gradient of
00 mm Hg was used. Ultrafiltration was performed at 200 mL/
in, and the blood was returned to the venous reservoir after
ltration. Ultrafiltration was started 20 minutes before the reper-
usion of the transplanted lung and continued until the termination
f CPB. A total of 2000 mL of normal saline was infused into the
enous reservoir, and the priming volume, including the additional
nfusion, was completely removed.
nimal Care
ll animals received humane care in compliance with the “Prin-
iples of laboratory animal care” formulated by the National
ociety of Medical Research and the “Guide for the care and use
f laboratory animals” prepared by the Institute of Laboratory
nimal Resources, National Research Council, and published by
he National Academy Press, revised 1996. The institutional re-
iew committee approved the study protocol.
easurement of Wet/Dry Lung Weight Ratio
he left upper and lower lobes were used to measure the wet/dry
eight (W/D) ratio. The lungs were weighed and then dried in an
ven at a constant temperature of 80°C for 48 hours. The W/D
atio was obtained by dividing the wet weight by the final dry
eight.
istopathologic Studies
ung specimens harvested at the time of animal death were fixed
ith 10% formalin. The tissues, cut into 4-m sections, were
tained with hematoxylin and eosin and with naphthol AS-D
hloroacetate esterase. Polymorphonuclear neutrophils (PMNs)
ere identified by means of positive staining and were counted at
00 magnification by 2 investigators who were blind to the
pecimens. The data were expressed as PMNs per alveolus.
yeloperoxidase Assay
he recipient lung samples were frozen in liquid nitrogen and
tored at80°C until assay. Quantitative myeloperoxidase (MPO)
ctivity was determined as previously described.16 Results were
xpressed as MPO per minute per 1 mg of tissue corrected for dry
eight (change in optical density per minute per milligram).
tatistical Analysis
ata were expressed as means  standard deviation. Data for
ultiple observations over time were analyzed by means of
-way analysis of variance (ANOVA) with repeated measures
or overall treatment effect. One-way ANOVA was used to test
or differences among treatment groups. When ANOVA
howed significance, the Tukey test was used for post-hoc
ultiple comparisons between treatment groups. All analyses
ere performed with SPSS 13.0J (SPSS Japan Inc) and SAS 8.2SAS Institute Inc) software.
and Cardiovascular Surgery ● Volume 132, Number 6 1449
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1
TXesults
here were no differences among the 3 groups with respect
o donor/recipient body weight ratio, cold ischemic time,
arm ischemic time, implantation time, body temperature,
nd the amount of heparin and protamine used (Table 1
ecipient animals survived the 6-hour observation period.
ung Function and Hemodynamic Changes
comparison of the 3 groups and the differences among the
groups for every measurement of arterial oxygen and
lveolar to arterial gradient for O2 are shown in Figure 
he PaO2 level was excellent in the animals undergoing
ransplantation without CPB during the 6-hour observation
eriod. However, in animals undergoing transplantation
ith CPB, the PaO2 level progressively deteriorated, and
ignificant differences were found among the 3 groups
overall group effect, P  .001; group 1 vs group 2, P 
001; group 2 vs group 3, P  .028). The PaO2 level of the
nimals undergoing transplantation with CPB was better
ith the use of ultrafiltration during the early reperfusion
eriod. The alveolar to arterial gradient for O2 of the ani-
als undergoing transplantation without CPB was signifi-
antly better than that of the animals undergoing transplan-
ation with CPB (overall group effect, P  .003; group 1 vs
roup 2, P  .002; group 2 vs group 3, not significant). The
emodynamic data of the recipients during the 6-hour ob-
ervation period are shown in Table 2. All 3 groups
imilar mean aortic pressure, CVP, LAP, and CO values.
he animals undergoing transplantation with CPB and ul-
rafiltration had significantly lower mean pulmonary artery
ressures than the animals undergoing transplantation with-
ut CPB (overall group effect, P  .012; group 1 vs group
, P  .011). Although the P value of the overall group
ffect for PVR was not significant (P  .068), the PVR of
nimals undergoing transplantation with CPB and ultrafil-
ration was lower than that of animals undergoing transplan-
ABLE 1. Characteristics of the 3 experimental groups
haracteristic Group 1 Group 2 Group 3
onor weight (kg) 20.4 1.3 19.6 2.1 19.9 1.9
ecipient weight (kg) 16.6 1.1 16.1 3.2 15.9 2.8
atio of donor/recipient
weight
1.22 0.01 1.24 0.17 1.25 0.04
old ischemic time
(min)
1212 13 1188 58 1197 11
arm ischemic time
(min)
62.2 9.3 62.6 7.1 70.6 9.6
xygenation capacity
(PaO2:FIO2  1.0)
564.8 47.1 608.7 46.1 598.5 38.3
eparin use (mL) 4.9 0.3 4.8 1.0 4.8 0.8
ody temperature (°C) 35.9 0.6 35.8 0.9 35.7 0.7
IO2 , Fraction of inhaled oxygen.ation without CPB at 4 and 6 hours after ligation of the h
450 The Journal of Thoracic and Cardiovascular Surgery ● Decll
d
ight pulmonary artery and bronchus. Regarding aerody-
amic parameters, peak airway pressure was essentially the
ame among the 3 groups.
istologic Findings
he microscopic findings for each group are shown in
igure 2. Neutrophil infiltration into the interstitial 
lveolar spaces was observed in all groups. These changes
ere most marked in the animals undergoing transplanta-
ion with CPB. The mean PMN infiltration number per
lveolus was 6.0  1.2 in group 1, 13.2  2 in group 2, and
.2  1.3 in group 3. PMN infiltration was significantly
igher in group 2 than in the other 2 groups (P  .001).
evere perivascular hemorrhage, in addition to alveolar
xudates and hemorrhage, was seen in animals undergoing
ransplantation with CPB. Ultrafiltration attenuated these
igure 1. PaO2 and alveolar to arterial gradient for O2 (A-aDO2)
evels of recipients in the 3 groups. Time course of PaO2 and
-aDO2 values before transplantation (before Tx) to 6 hours after
igation of the right pulmonary artery and the right bronchus in
roup 1 (filled circles), group 2 (filled triangles), and group 3 (open
ircles) is shown. Each group consisted of 5 animals. Significant
ifferences in PaO2 levels were observed among the groups
overall group effect, P .001, group 1 vs group 2, P .001; group
vs group 3, P  .028). Significant differences in A-aDO2 values
ere observed among the groups (overall group effect, P .003;
roup 1 vs group 2, P  .002).istologic changes.
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TXPO Assay
he MPO activity of the graft was 0.32  0.02 min/mg for
nimals undergoing transplantation without CPB, 0.41 0.04
in/mg for animals undergoing transplantation with CPB, and
.16  0.04 min/mg for animals undergoing transplantation
ith CPB and ultrafiltration. The MPO activity of the lungs
ransplanted with CPB was higher than that of the lungs trans-
lanted without CPB (P  .04). Simultaneous use of CPB and
ltrafiltration significantly suppressed MPO activity (P  .02).
/D Ratio
he W/D ratio of the transplanted lung after 6 hours was
ABLE 2. Changes of lung and cardiac function of the gra
Before Tx 1 h 2 h
AWP (mm Hg)
Group 1 17.6 0.9 20.8 4.4 20.8 4.4
Group 2 18.0 0.0 22.0 3.7 21.5 4.1
Group 3 17.6 2.2 20.8 3.3 21.2 3.6
R (beats/min)
Group 1 163.2 8.8 175.8 8.7 180.6 8.5 1
Group 2 180.0 18.4 176.6 9.6 182.6 14.3 1
Group 3 174.6 7.4 174.4 4.4 175.0 5.5 1
AoP (mm Hg)
Group 1 145.2 15.6 119.0 25.3 115.8 19.6 1
Group 2 150.8 8.9 109.0 10.3 121.6 18.4 1
Group 3 137.6 5.9 98.6 11.3 108.8 11.0 1
VP (mm Hg)
Group 1 8.4 0.5 5.2 0.7 6.0 0.6
Group 2 7.4 0.9 7.2 0.6 7.2 0.4
Group 3 7.8 0.4 6.0 0.4 5.2 0.7
AP (mm Hg)
Group 1 10.0 0.0 7.8 0.6 8.0 0.5
Group 2 9.2 1.1 6.6 0.5 7.2 0.4
Group 3 9.4 2.9 7.8 0.2 6.0 0.3‡
PAP (mm Hg)
Group 1 20.6 1.5 32.0 9.6 30.8 8.6
Group 2 17.8 2.5 25.2 4.3 24.2 4.6
Group 3 19.8 1.9 23.4 2.5 21.0 1.6‡
VR
Group 1 346.6 73.8 1496.1 767.1 1474.1 677.8 16
Group 2 248.7 112.3 1070.8 305.0 1284.6 511.4 12
Group 3 298.8 69.1 811.1 233.1 929.6 195.2 9
O (L/min)
Group 1 2.5 0.2 1.3 0.4 1.2 0.2
Group 2 2.9 0.6 1.4 0.2 1.2 0.4
Group 3 2.8 0.5 1.6 0.4 1.3 0.1
efore Tx, Before transplantation; PAWP, peak airway pressure; HR, heart
ressure; MPAP, mean pulmonary pressure; PVR, pulmonary vascular resi
versus group 3: ‡P  .05, §P  .01..49  1.05 for animals undergoing transplantation without m
The Journal of ThoracicPB, 8.71  1.20 for animals undergoing transplantation
ith CPB, and 7.37  0.40 for animals undergoing trans-
lantation with CPB and ultrafiltration. There were no sig-
ificant differences with respect to the W/D lung weight
atio among the 3 groups.
AL Results
here were no statistically significant differences among the
groups in recovery rates and total cell numbers in the BAL
uid. The protein concentration of the BAL fluid obtained
hours after reperfusion was 0.16  0.05 mg/dL for ani-
als undergoing transplantation without CPB, 0.40  0.16
h 4 h 5 h 6 h
P value
(overall
group
effect)
4.1 22.0 5.8 22.0 5.8 22.4 5.5 .819
4.1 23.6 4.6 23.2 4.6 23.2 3.9
4.3 20.8 3.0 21.6 3.3 21.6 3.8
8.7 199.8 9.7 201.8 9.8 202.6 11.7 .867
13.3 191.8 11.2 201.4 7.3 204.0 9.9
7.0 185.8 7.2 193.2 7.2 198.4 4.2
16.5 92.8 13.8 98.2 6.5 95.2 11.6 .382
20.5 113.0 14.9 101.0 14.1 88.0 20.2
10.3 105.6 9.4 98.2 15.2 87.8 10.8
0.6 6.6 0.7 6.2 0.7 6.4 0.9 .450
0.8 6.6 0.2 6.6 0.2 7.2 0.2
0.5 6.2 0.4 6.0 0.6 7.0 0.5
1.6 8.0 2.9 7.8 1.5 7.4 1.1 .062
1.1 6.4 0.9 5.8 0.8 6.0 0.7
0.5 6.4 0.5* 6.0 1.0 7.2 1.6
7.1 33.4 5.7 34.2 6.3 33.8 6.7 .012
4.1 25.8 5.4 25.4 4.6* 27.2 6.1
2.5 20.2 2.0§ 23.4 3.1‡ 23.8 2.2‡
489.4 1718.9 377.5 1709.0 675.3 1674.4 392.4 .068
432.5 1337.6 481.1 1333.8 343.2 1407.8 329.7
240.7 1009.5 246.8‡ 1377.3 439.2 838.3 304.6‡
0.2 1.2 0.2 1.3 0.2 1.3 0.2 .593
0.3 1.2 0.4 1.2 0.4 1.2 0.3
0.1 1.1 0.1 1.0 0.2 1.7 0.5
AoP, mean aortic pressure; CVP, central venous pressure; LAP, left atrial
e; CO, cardiac output. Group 1 versus group 2: *P  .05, †P  .01. Groupft
3
20.8
22.8
21.6
93.0
79.4
77.0
14.6
15.0
06.4
5.8
6.2
5.8
8.2
6.8
6.6
31.4
24.8
20.0
08.9
77.3
30.3
1.1
1.2
1.2
rate; m
stancg/dL for animals undergoing transplantation with CPB,
and Cardiovascular Surgery ● Volume 132, Number 6 1451
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1
TXnd 0.12  0.04 mg/dL for animals undergoing transplan-
ation with CPB and ultrafiltration. The protein level of the
nimals undergoing transplantation with CPB and ultrafil-
ration was lower than that of the animals undergoing trans-
lantation with CPB (P  .02), whereas the serum protein
evels of the 3 groups were essentially the same (2.53 
.26 mg/dL for group 1, 2.45 0.54 mg/dL for group 2, and
.40  0.54 mg/dL for group 3).
Interleukin 6 (IL-6) mRNA expression in the lung is
iscussed in Appendix E1 and Figure E1.
iscussion
he use of CPB in lung transplantation remains controver-
ial because clinical and experimental studies have reported
ifferent conclusions.1-4,8,9,12,13 CPB is known to stimula
nd release several mediators, including complement fac-
ors.4-6 At the time of reperfusion, the blood activated
PB goes into the newly transplanted lung, and reperfusion
njury could be more severely accelerated compared with
ases in which the blood is not activated. On the other hand,
PB has a beneficial effect in that the transplanted lungs can
e reperfused with controlled pulmonary artery pressure.
everal studies have demonstrated that decreasing the reper-
usion pressure reduces lung injury after lung ischemia.10,11
herefore one could expect that CPB should have beneficial
ffects by preventing high pulmonary flow during reperfu-
ion of the transplanted lung.
In the present experiment all animals survived the 6-hour
Figure 2. The histopathologic appearance of the graft f
isolated single neutrophils are present, mainly withi
evident (lower). Group 2, A substantial increase in the
(upper). In addition to diffuse alveolar edema, alveolar e
observed (lower). Group 3, Neutrophil infiltration is m
hemorrhage (upper). There is mild edema but no hemobservation period, which is in contrast to other reports in C
452 The Journal of Thoracic and Cardiovascular Surgery ● Dechich animals could not tolerate contralateral pulmonary
rtery clamping for longer than 2 hours.12 The reason for th
ifferences in survival could be the different reperfusion
ethods. In previous canine experiments the animals were
uickly weaned off CPB, and the potential benefit of CPB
as not fully examined. We believe that that the decreasing
f the pulmonary pressure in our model ameliorated graft
unction to some extent. However, our data indicated that
ven if pulmonary flow was controlled during reperfusion,
ulmonary function eventually deteriorated over the 6-hour
bservation period, and the graft was not permanently pro-
ected from the adverse effects of CPB.
Our study has several limitations. First, the animals un-
erwent transplantation with unilateral lungs and vascular
eds that were smaller than in bilateral lung transplantation.
owever, a donor/recipient body weight ratio of 1.2 or
reater was used in this study. Second, canines are thought
o be more susceptible to CPB than human subjects. Third,
ost of the animals undergoing transplantation with CPB
equired blood transfusion, whereas the animals undergoing
ransplantation without CPB did not. This might have ac-
elerated the worsening of graft function. Halldorsson and
oworkers10,11 reported that controlled reperfusion preven
ulmonary injury after 24 hours of lung preservation. In
heir experiment white blood cells were depleted through a
eukocyte-depleting filter. Bando and associates17 reported
imilar results in lung injury associated with CPB. They
howed that leukocyte depletion improves lung injury after
he 3 groups is shown. Group 1, A moderate number of
eolar capillaries (upper). Perivascular edema is not
er of neutrophils present in the alveolar wall is seen
tes, and hemorrhage, perivascular hemorrhage is also
dly attenuated. There are no alveolar exudates and
ge in the perivascular space (lower).rom t
n alv
numb
xuda
arke
rrhaPB. In our experiment leukocyte depletion was not ap-
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TXlied; this could explain why there was graft dysfunction
espite the prevention of high-flow vascular injury. In fact,
he changes observed on histology and the MPO assay were
ot those of simple lung edema but the result of accumula-
ion of PMNs into the alveolar space. These changes are
ompatible with those found in lungs after cardiac surgery
ith CPB.18 It is well known that there is an inflamma
eaction to CPB with neutrophil sequestration in the lungs,
ontributing to microvascular injury and postoperative pul-
onary dysfunction. Therefore in our model reperfusion
ulmonary injury of the transplanted lung might have been
urther enhanced by the adverse effect of CPB.
Recently, ultrafiltration techniques have been shown to
mprove postoperative respiratory and cardiac functions af-
er heart surgery. Furthermore, ultrafiltration has been in-
estigated as a potential therapy for severe acute respiratory
yndrome because it removes inflammatory mediators and
xcess free water. Thus we hypothesized that ultrafiltration
ould reduce inflammatory mediators and be beneficial for
raft function in lung transplantation with CPB. CUF is
pplied during the rewarming phase of CPB, and modified
ltrafiltration (MUF) is performed immediately after cessa-
ion of CPB; both methods are used in cardiac surgery19-21
erdat and associates20 reported that in pediatric cardi
urgery both CUF and MUF could remove inflammatory
ediators. They reported that of the cytokines, IL-6 was
emoved most effectively and that IL-6 was removed to a
reater extent with CUF than with MUF. IL-6 is known to
e the key cytokine associated with sequestration of neu-
rophils in the lung.22 IL-6 stimulates neutrophilia an
hrombopoiesis and induces the synthesis of acute-phase
roteins.22-24 Sustained increased of IL-6 in the plasma 
AL fluid of patients with adult respiratory distress syn-
rome have been demonstrated and are negatively corre-
ated with disease outcome and patient survival.25 In this
xperiment we used the CUF method. We were not able to
how whether the improvement of graft function was
rought about by the reduction of IL-6 levels in the present
tudy because the specific cytokine kit for canine IL-6 is not
et commercially available. Therefore instead of measuring
erum cytokine levels, we showed that IL-6 mRNA was
educed in canines with ultrafiltration by using real-time
everse transcription–polymerase chain reaction (see A
endix E1 and Figure E1). Another possible mechanism
hich ultrafiltration could improve graft function might be
ue to the reduction of adhesion molecules on recipients’
lood lymphocytes. It is well known that some adhesion
olecules are upregulated during CPB and have been asso-
iated with the adverse effects of CPB.26 Grunenfelder and
ssociates27 reported that ultrafiltration led to a signific
eduction in not only cytokines but also adhesion molecules,
uch as soluble E-selectin and intercellular adhesion mole-
ule 1. Both molecules are responsible for the primary
The Journal of Thoracicdhesion of neutrophils to the endothelium of the vessels.
hus several mechanisms might contribute to the changes
bserved in grafts treated with CUF. Given our results,
urther study to determine the optimal ultrafiltration method
or patients undergoing lung transplantation with CPB is
arranted.
In conclusion, despite controlling pulmonary flow during
he reperfusion period, CPB has deleterious effects on the
raft in a canine single-lung transplantation model. Ultra-
ltration applied during termination of CPB might improve
raft function by reducing the inflammatory response
hrough several mechanisms.
We gratefully acknowledge the expert technical assistance of
yu-ichi Higuchi with the surgical preparation of the dogs.
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Saitoh et al Cardiothoracic Transplantationppendix E1. IL-6 mRNA expression in the lung
ung tissue was collected in tubes containing TRIZOL reagent
Invitrogen Japan K.K.) and stored at 80°C until analysis to
solate total RNA from the lungs. Samples were incubated for 15
inutes at 30°C to permit complete tissue dissociation. Samples
ere mixed with 0.2 mL of chloroform per 1 mL of TRIZOL and
ere centrifuged at 12,000g for 15 minutes at 8°C. The aqueous
hase was collected and transferred to fresh tubes. The RNA was
recipitated by mixing with isopropyl alcohol. After incubation for
5 minutes at 30°C, samples were centrifuged at 12,000g for 10
inutes. The supernatant was removed, and 75% ethanol was
dded to the RNA pellet, which was then mixed by vortexing and
entrifuged at 7500g for 5 minutes at 4°C. Finally, the dried RNA
as isolated. Reverse transcription was done with 5 L of hot-
enatured DNA-free RNA, 100 pmol of random hexamer primers
pd5[N6], Amersham Pharmacia Biotech), and 100 U of Super-
cript II reverse transcriptase (Roche Diagnostics). The reaction
ixture was incubated for 10 minutes at 20°C, 30 minutes at 42°C,
nd 5 minutes at 37°C. Products were precipitated with NaOAc
0.3 M, pH 6) and 2.5 volumes of ethanol (95%). They were then
esuspended in 30 l of diethylpyrocarbonate-water and stored at
20°C. cDNA was diluted 100-fold with DNAse-free water in a
iliconized tube (which had 10 ng/L MS2 RNA to prevent
dherence to the tube wall), and 5 L was then used for real-time
CR. Real-time reverse transcription–polymerase chain reaction on
he LightCycler (Roche Diagnostics) was done with a total volume
f 20 L in the presence of 2 L of 10 reaction buffer (Taq u
The Journal of Thoracic anolymerase, deoxyribonucleoside triphosphates, MgCl2, SYBR
reen, Roche Diagnostics) and 2 L of cDNA (or water as a
egative control, which was always included). MgCl2 was added
o a final concentration of 4 mM, and 11.25 pmol of each oligo-
ucleotide primer (Actin-LF: CCCAAGGCCAACCGCGAGAA-
AT, product size, 219 bp; Actin-LR: GTCCCGGCCAGCCAG-
TCCAG; IL6-LF: AAGGGGCATCTCCAACATCATCAT, 332
p; IL6-LR: CTCCTGCCAAGCTGAACCCAAGAC) was added.
eal-time PCR was performed in glass capillaries with an initial
enaturation step of 30 seconds at 95°C, followed by 40 cycles of
seconds at 95°C, 5 seconds at annealing temperature (-actin,
6°C; IL-6, 62°C), and (product length [bp]/25) seconds at 72°C.
t the end of each cycle, the fluorescence emitted by the SYBR
reen was measured. After completion of the cycling process,
amples were subjected to a temperature ramp (from 5°C above
nnealing temperature to 95°C at 2°C/s) with continuous fluores-
ence monitoring for the melting curve analysis. The relative
uantification analyses the actual amount of a particular target
ranscript relative to an internal standard (a housekeeping gene) in
he same sample. Results were expressed as the target/internal
tandard concentration ratio of the sample divided by the target/
nternal standard concentration ratio of the calibrator.
The average and standard deviation of relative gene expression
f IL-6 of normal lungs and the experimental groups’ lungs are
hown in Figure E1.Expression of IL-6 was significantly increased
n group 2 over that in group 1 (P  .024). Simultaneous use of
ltrafiltration suppressed IL-6 (P  .047, group 2 vs group 3).
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TXigure E1. The average and standard deviation of relative gene
xpression of IL-6 of normal lungs and the experimental groups.ecember 2006
